-
Comparing the Time to Reimbursement of the Orphan Drug Evrysdi in Turkiye vs. Euro-5 Markets
Sep 9, 2025, 16:22 PM -
Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Hospitalization Burden in Norway
Sep 9, 2025, 16:22 PM -
Turning SAP Feedback into HTA-Ready Action: A Semi-Automated Approach for RWD Studies
Sep 9, 2025, 16:22 PM -
Effectiveness of Subcutaneous Natalizumab in Multiple Sclerosis: Real-World Evidence From a Finnish Registry Study
Sep 9, 2025, 16:22 PM -
Unseen Burdens of Glycogen Storage Disease Type Ia (GSDIa) Experienced by Patients, Caregivers, and their Healthcare Team
Sep 9, 2025, 16:22 PM -
Evaluation of the Article 51 VIGIE-AGE Experiment: A Significant Impact on Hospitalizations Resulting in Reduced Total Expenditure
Sep 9, 2025, 16:22 PM -
Gaps in Evidence on Burden and HRQoL in Small-Cell Lung Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Prevalence Utilization Patterns and Economic Impact of eGFR and ALK-Targeted Therapies in Non-Small Cell Lung Cancer: A Nationwide Real-World Analysis From Greece
Sep 9, 2025, 16:22 PM -
Epidemiology and Outcomes in a Linked Cohort of Cancer Pathology and Electronic Medical Records From the PHARMO Data Network
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Using Site-Specific Wastewater-Based Surveillance to Monitor COVID-19 in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Direct Healthcare Costs (HCCs) Inequalities Associated With Myasthenia Gravis (MG) in Hungary: Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Patients With Metastatic Urothelial Cancer: Results of a Cross-Sectional Survey in Europe
Sep 9, 2025, 16:22 PM -
Multicriteria Health Technology Assessments for High-Cost Oncology Drugs in Peru: A Cross-Sectional Study of RENETSA Records 2023-2024
Sep 9, 2025, 16:22 PM -
A Record-Level Risk Metric for Partially Synthetic Clinical Data Using Inverse-Square Similarity Decay
Sep 9, 2025, 16:22 PM -
Assessing the Real-World Impact of Earlier Initiation of Anti-Tumor Necrosis Factor vs. Conventional Synthetic DMARDs on Clinical and Patient-Reported Outcomes in Patients With Rheumatoid Arthritis in Europe
Sep 9, 2025, 16:22 PM -
Correspondence Between Patients' and Neurologists' Satisfaction With Treatment in Patients With CIDP: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
Importance of Decisional Context in the Health Technology Assessment (HTA) of Ultra-Orphan Drugs
Sep 9, 2025, 16:22 PM -
The Role of Qualitative Research in Randomized Controlled Trials Involving Drugs and Medical Devices: A Systematic Mapping Review
Sep 9, 2025, 16:22 PM -
Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Tenecteplase vs. Alteplase for Adults With Acute Ischemic Stroke (AIS) in Greece
Sep 9, 2025, 16:22 PM
